Journal for ImmunoTherapy of Cancer
Impact Factor & Key Scientometrics

Journal for ImmunoTherapy of Cancer
Overview

Impact Factor

13.751

H Index

117

Impact Factor

10.677

I. Basic Journal Info

Country

United Kingdom
Journal ISSN: 20511426
Publisher: BMJ Publishing Group
History: 2013-2020
Journal Hompage: Link
How to Get Published:

Research Categories

Scope/Description:

The Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed, online journal of the Society for Immunotherapy of Cancer (SITC). The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance scientific understanding among the many stakeholders in this rapidly evolving field. Topics of interest range widely across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.

II. Science Citation Report (SCR)



Journal for ImmunoTherapy of Cancer
SCR Impact Factor

Journal for ImmunoTherapy of Cancer
SCR Journal Ranking

Journal for ImmunoTherapy of Cancer
SCImago SJR Rank

SCImago Journal Rank (SJR indicator) is a measure of scientific influence of scholarly journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from.

5.06

Journal for ImmunoTherapy of Cancer
Scopus 2-Year Impact Factor Trend

Note: impact factor data for reference only

Journal for ImmunoTherapy of Cancer
Scopus 3-Year Impact Factor Trend

Note: impact factor data for reference only

Journal for ImmunoTherapy of Cancer
Scopus 4-Year Impact Factor Trend

Note: impact factor data for reference only

Journal for ImmunoTherapy of Cancer
Impact Factor History

2-year 3-year 4-year
  • 2023 Impact Factor
    #N/A #N/A #N/A
  • 2022 Impact Factor
    8.881 10.232 10.936
  • 2021 Impact Factor
    10.677 12.014 12.33
  • 2020 Impact Factor
    11.367 11.636 11.259
  • 2019 Impact Factor
    9.093 8.973 8.258
  • 2018 Impact Factor
    7.758 7.283 7.235
  • 2017 Impact Factor
    5.798 6.112 6.042
  • 2016 Impact Factor
    5.112 5.212 5.212
  • 2015 Impact Factor
    4.968 5.016 5.016
  • 2014 Impact Factor
    2.238 NA NA
  • 2013 Impact Factor
    0 NA NA
  • 2012 Impact Factor
    NA NA NA
  • 2011 Impact Factor
    NA NA NA
  • 2010 Impact Factor
    NA NA NA
  • 2009 Impact Factor
    NA NA NA
  • 2008 Impact Factor
    NA NA NA
  • 2007 Impact Factor
    NA NA NA
  • 2006 Impact Factor
    NA NA NA
  • 2005 Impact Factor
    NA NA NA
  • 2004 Impact Factor
    NA NA NA
  • 2003 Impact Factor
    NA NA NA
  • 2002 Impact Factor
    NA NA NA
  • 2001 Impact Factor
    NA NA NA
  • 2000 Impact Factor
    NA NA NA
Note: impact factor data for reference only

HIGHEST PAID JOBS

LATEX TUTORIALS

MUST-READ BOOKS


Impact Factor

Impact factor (IF) is a scientometric factor based on the yearly average number of citations on articles published by a particular journal in the last two years. A journal impact factor is frequently used as a proxy for the relative importance of a journal within its field. Find out more: What is a good impact factor?


III. Other Science Influence Indicators

Any impact factor or scientometric indicator alone will not give you the full picture of a science journal. There are also other factors such as H-Index, Self-Citation Ratio, SJR, SNIP, etc. Researchers may also consider the practical aspect of a journal such as publication fees, acceptance rate, review speed. (Learn More)

Journal for ImmunoTherapy of Cancer
H-Index

The h-index is an author-level metric that attempts to measure both the productivity and citation impact of the publications of a scientist or scholar. The index is based on the set of the scientist's most cited papers and the number of citations that they have received in other publications

117

Journal for ImmunoTherapy of Cancer
H-Index History